Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin-like Growth Factor II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Not applicableNot Yet RecruitingNCT06594042
What this trial is testing

Serum Preptin Level and Its Relationship With Bone Mineral Disease in Chronic Kidney Disease Patients

Who this might be right for
Preptin
Assiut University 96
Testing effectiveness (Phase 2)Study completedNCT00577577
What this trial is testing

Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy Type 1
Insmed Incorporated 69
Testing effectiveness (Phase 2)Ended earlyNCT01609231
What this trial is testing

A Trial of Dalotuzumab in Combination With Irinotecan Versus Cetuximab and Irinotecan for Participants With Metastatic Rectal Cancers (mRC) (MK-0646-025)

Who this might be right for
Rectal Neoplasms
Merck Sharp & Dohme LLC 11
Early research (Phase 1)Study completedNCT00816361
What this trial is testing

A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors

Who this might be right for
Cancer
MedImmune LLC 43
Testing effectiveness (Phase 2)Study completedNCT00684983
What this trial is testing

Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer

Who this might be right for
HER2 Positive Breast CarcinomaRecurrent Breast CarcinomaStage IIIB Breast Cancer AJCC v7+2 more
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Ended earlyNCT00718523
What this trial is testing

Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Translational Research in Oncology 170
Testing effectiveness (Phase 2)Study completedNCT00769795
What this trial is testing

Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 29
Testing effectiveness (Phase 2)Study completedNCT00965250
What this trial is testing

Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy

Who this might be right for
ThymomaThymic CarcinomaThymic Carcinoid+1 more
National Cancer Institute (NCI) 49
Not applicableNot Yet RecruitingNCT07736079
What this trial is testing

Evaluation of Serum Preptin Levels in Patients With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome (PCOS)Insulin Resistance
GÜLDEN ANATACA 60
Not applicableAvailableNCT07262970
What this trial is testing

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Who this might be right for
Tumor-associated Hyperinsulinism (Tumor HI)
Rezolute
Testing effectiveness (Phase 2)Ended earlyNCT03041701
What this trial is testing

Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma

Who this might be right for
RhabdomyosarcomaRhabdomyosarcoma, AlveolarRhabdomyosarcoma, Embryonal
National Cancer Institute (NCI) 14